Nodal reactive and neoplastic proliferation of monocytoid and marginal zone B cells: An immunoarchitectural and molecular study highlighting the relevance of IRTA1 and T-bet as positive markers

Histopathology

Volumn 63, Issue 4, 2013, Pages 482-498

  Bob, Roshanak ^a,b   Falini, Brunangelo ^c   Marafioti, Teresa ^d   Paterson, Jennifer C ^d   Pileri, Stefano ^e   Stein, Harald ^a  

^a Pathodiagnostik Berlin   (Germany)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^c UNIVERSITY OF PERUGIA   (Italy)

^d UNIVERSITY COLLEGE HOSPITAL   (United Kingdom)

^e UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

IRTA1 MUM2; Marginal zone expansion; Monocytoid B cells; Nodal marginal zone lymphoma; T bet

Indexed keywords

BIOLOGICAL MARKER; CD20 ANTIGEN; CD23 ANTIGEN; CD3 ANTIGEN; CD30 ANTIGEN; CD5 ANTIGEN; COMMON ACUTE LYMPHOBLASTIC LEUKEMIA ANTIGEN; CYCLIN D1; IMMUNOGLOBULIN D; IMMUNOGLOBULIN LIGHT CHAIN; IRTA1 PROTEIN; KI 67 ANTIGEN; LIPOCORTIN 1; PROTEIN BCL 2; PROTEIN BCL 6; TRANSCRIPTION FACTOR T BET; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CELL EXPANSION; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENE REARRANGEMENT; HUMAN; HUMAN CELL; IMMUNOGLOBULIN GENE; IMMUNOHISTOCHEMISTRY; IMMUNOPHENOTYPING; LYMPHOCYTE; LYMPHOCYTE PROLIFERATION; LYMPHOCYTE STRUCTURE; LYMPHOCYTIC INFILTRATION; LYMPHOID CELL; MALE; MARGINAL ZONE B CELL; MONOCYTOID B CELL; NODAL MARGINAL ZONE LYMPHOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION;

IRTA1/MUM2; MARGINAL ZONE EXPANSION; MONOCYTOID B CELLS; NODAL MARGINAL ZONE LYMPHOMA; T-BET;

ADULT; AGED; AGED, 80 AND OVER; B-LYMPHOCYTES; CELL PROLIFERATION; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; IMMUNOPHENOTYPING; IN SITU HYBRIDIZATION, FLUORESCENCE; LYMPH NODES; LYMPHOMA, B-CELL, MARGINAL ZONE; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; RECEPTORS, FC; T-BOX DOMAIN PROTEINS; TUMOR MARKERS, BIOLOGICAL;

EID: 84884709676     PISSN: 03090167     EISSN: 13652559     Source Type: Journal    
DOI: 10.1111/his.12160     Document Type: Article

References (38)

1. Jaffe ES, Harris NL, Vardiman JW, Campo E, Arber DA. Hematopathology. Philadelphia, PA: Saunders/Elsevier, 2011; 104.
2. Arcaini L, Lucioni M, Bover E, Paulli M. Nodal marginal zone lymphoma: current knowledge and future directions of a heterogeneous disease. Eur. J. Haematol. 2009; 83; 165-174.
3. Sheibani K, Fritz RM, Winberg CD, Burke JS, Rappaport H. Monocytoid cells in reactive follicular hyperplasia with and without multifocal histiocytic reactions: an immunohistochemical study of 21 cases including suspected cases of toxoplasmic lymphadenitis. Am. J. Clin. Pathol. 1984; 81; 453-458.
4. Stein H, Lennert K, Mason DY, Liangru S, Ziegler A. Immature sinus histiocytes. Their identification as a novel B-cell population. Am. J. Pathol. 1984; 117; 44-52.
5. Anagnostopoulos I, Hummel M, Falini B, Joehrens K, Stein H. Epstein-Barr virus infection of monocytoid B-cell proliferates: an early feature of primary viral infection? Am. J. Surg. Pathol. 2005; 29; 595-601.
6. Cousar JB, McGinn DL, Glick AD, List AF, Collins RD. Report of an unusual lymphoma arising from parafollicular B-lymphocytes (PBLs) or so-called 'monocytoid' lymphocytes. Am. J. Clin. Pathol. 1987; 87; 121-128.
7. Joubert M, Morin C, Moreau A, Heymann MF, Laboisse C, Gaillard F. Histopathologic features of cytomegalovirus lymphadenitis in the 'immunocompetent' patient. Report of 7 cases. Ann. Pathol. 1996; 16; 254-260.
8. Kojima M, Nakamura S, Itoh H et al. Occurrence of monocytoid B-cells in reactive lymph node lesions. Pathol. Res. Pract. 1998; 194; 559-565.
9. Sheibani K, Sohn CC, Burke JS, Winberg CD, Wu AM, Rappaport H. Monocytoid B-cell lymphoma. A novel B-cell neoplasm. Am. J. Pathol. 1986; 124; 310-318.
10. Harris NL, Jaffe ES, Stein H et al. A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group. Blood 1994; 84; 1361-1392.
11. Piris MA, Rivas C, Morente M, Cruz MA, Rubio C, Oliva H. Monocytoid B-cell lymphoma, a tumour related to the marginal zone. Histopathology 1988; 12; 383-392.
12. Salama ME, Lossos IS, Warnke RA, Natkunam Y. Immunoarchitectural patterns in nodal marginal zone B-cell lymphoma: a study of 51 cases. Am. J. Clin. Pathol. 2009; 132; 39-49.
13. Swerdlow SH, Campo E, Harris NL et al. World Health Organization classification of tumours of haematopoietic and lymphoid tissues. Lyon: IARC Press, 2008; 218-219.
14. Attygalle AD, Liu H, Shirali S et al. Atypical marginal zone hyperplasia of mucosa-associated lymphoid tissue: a reactive condition of childhood showing immunoglobulin lambda light-chain restriction. Blood 2004; 104; 3343-3348.
15. Camacho FI, García JF, Sánchez-Verde L et al. Unique phenotypic profile of monocytoid B cells: differences in comparison with the phenotypic profile observed in marginal zone B cells and so-called monocytoid B cell lymphoma. Am. J. Pathol. 2001; 158; 1363-1369.
16. Contos MJ, Kornstein MJ, Innes DJ, Ben-Ezra J. The utility of CD20 and CD43 in subclassification of low-grade B-cell lymphoma on paraffin sections. Mod. Pathol. 1992; 5; 631-633.
17. Van Krieken JH, von Schilling C, Kluin PM, Lennert K. Splenic marginal zone lymphocytes and related cells in the lymph node: a morphologic and immunohistochemical study. Hum. Pathol. 1989; 20; 320-325.
18. Lai R, Arber DA, Chang KL, Wilson CS, Weiss LM. Frequency of bcl-2 expression in non-Hodgkin's lymphoma: a study of 778 cases with comparison of marginal zone lymphoma and monocytoid B-cell hyperplasia. Mod. Pathol. 1998; 11; 864-869.
19. Falini B, Tiacci E, Pucciarini A et al. Expression of the IRTA1 receptor identifies intraepithelial and subepithelial marginal zone B cells of the mucosa-associated lymphoid tissue (MALT). Blood 2003; 102; 3684-3692.
20. Lazzi S, Bellan C, Tiacci E et al. IRTA1+ monocytoid B cells in reactive lymphadenitis show a unique topographic distribution and immunophenotype and a peculiar usage and mutational pattern of IgVH genes. J. Pathol. 2006; 209; 56-66.
21. Dorfman DM, Hwang ES, Shahsafaei A, Glimcher LH. T-bet, a T-cell-associated transcription factor, is expressed in a subset of B-cell lymphoproliferative disorders. Am. J. Clin. Pathol. 2004; 122; 292-297.
22. Jöhrens K, Shimizu Y, Anagnostopoulos I et al. T-bet-positive and IRTA1-positive monocytoid B cells differ from marginal zone B cells and epithelial-associated B cells in their antigen profile and topographical distribution. Haematologica 2005; 90; 1071-1077.
23. Falini B, Agostinelli C, Bigerna B et al. IRTA1 is selectively expressed in nodal and extranodal marginal zone lymphomas. Histopathology 2012; 61; 930-941.
24. van Dongen JJ, Langerak AW, Brüggemann M et al. Design and standardization of PCR primers and protocols for detection of clonal immunoglobulin and T-cell receptor gene recombinations in suspect lymphoproliferations: report of the BIOMED-2 Concerted Action BMH4-CT98-3936. Leukemia 2003; 17; 2257-2317.
25. Plank L, Hansmann ML, Fischer R. The cytological spectrum of the monocytoid B-cell reaction: recognition of its large cell type. Histopathology 1993; 23; 425-431.
26. Marafioti T, Jones M, Facchetti F, Diss TC, Du MQ. Phenotype and genotype of interfollicular large B cells, a subpopulation of lymphocytes often with dendritic morphology. Blood 2003; 102; 2868-2876.
27. Campo E, Miquel R, Krenacs L, Sorbara L, Raffeld M, Jaffe ES. Primary nodal marginal zone lymphomas of splenic and MALT type. Am. J. Surg. Pathol. 1999; 23; 59-68.
28. Dorfman DM, van den Elzen P, Weng AP, Shahsafaei A, Glimcher LH. Differential expression of T-bet, a T-box transcription factor required for Th1 T-cell development, in peripheral T-cell lymphomas. Am. J. Clin. Pathol. 2003; 120; 866-873.
29. Iwai Y, Okazaki T, Nishimura H, Kawasaki A, Yagita H, Honjo T. Microanatomical localization of PD-1 in human tonsils. Immunol. Lett. 2002; 83; 15-20.
30. Muenst S, Dirnhofer S, Tzankov A. Distribution of PD-1+ lymphocytes in reactive lymphadenopathies. Pathobiology 2010; 77; 24-27.
31. Hummel M, Anagnostopoulos I, Dallenbach F, Korbjuhn P, Dimmler C, Stein H. EBV infection patterns in Hodgkin's disease and normal lymphoid tissue: expression and cellular localization of EBV gene products. Br. J. Haematol. 1992; 82; 689-694.
32. Hunt JP, Chan JA, Samoszuk M et al. Hyperplasia of mantle/marginal zone B cells with clear cytoplasm in peripheral lymph nodes. A clinicopathologic study of 35 cases. Am. J. Clin. Pathol. 2001; 116; 550-559.
33. Camacho FI, Algara P, Mollejo M et al. Nodal marginal zone lymphoma: a heterogeneous tumor: a comprehensive analysis of a series of 27 cases. Am. J. Surg. Pathol. 2003; 27; 762-771.
34. Naresh KN. Nodal marginal zone B-cell lymphoma with prominent follicular colonization: difficulties in diagnosis: a study of 15 cases. Histopathology 2008; 52; 331-339.
35. Kojima M, Motoori T, Iijima M et al. Florid monocytoid B-cell hyperplasia resembling nodal marginal zone B-cell lymphoma of mucosa associated lymphoid tissue type. A histological and immunohistochemical study of four cases. Pathol. Res. Pract. 2006; 202; 877-882.
36. Kojima M, Nakamura S, Motoori T et al. Follicular hyperplasia presenting with a marginal zone pattern in a reactive lymph node lesion. A report of six cases. APMIS 2002; 110; 325-331.
37. Krishnan C, Warnke RA, Arber DA, Natkunam Y. PD-1 Expression in T-cell lymphomas and reactive lymphoid entities: potential overlap in staining patterns between lymphoma and viral lymphadenitis. Am. J. Surg. Pathol. 2010; 34; 178-189.
38. Muenst S, Hoeller S, Willi N, Dirnhofera S, Tzankov A. Diagnostic and prognostic utility of PD1 in B cell lymphomas. Dis. Markers 2010; 29; 47-53.